.
.jeffrey krasner is president of emerging biocommunications, which consults to early- and mid-stage life science companies.
.
.
.: "evidence for decreased calcitonin gene-related peptide (cgrp) receptors and compromised responsiveness to cgrp of fetoplacental vessels in preeclamptic pregnancies."
.